Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for Postoperative GI Recovery
NCT04355169Phase 2Terminated
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naldemedine in Postoperative gastrointestinal dysfunction (POGD), sponsored by Shionogi & Co., Ltd.. Started Nov 2020; status: terminated.
02
Drugs
naldemedine
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on NCT04355169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355169.